Expressions of TRPV1 in Airway of Asthmatics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-20

Study Completion Date

2018-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to measure the density of a temperature-sensitive protein, named TRPV1, in the airway mucosa tissue of both non-asthmatic and moderate to severe persistent asthmatic patients. This study may generate information for developing new therapeutic strategy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Airway Temperature

NCT02401074

Asthma

WITHDRAWN PHASE1

Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm

NCT00710255

Asthma, Exercise Induced

COMPLETED

Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma

NCT02241265

Asthma

RECRUITING

Role of TLR4 in Environmental Asthma

NCT00671892

Asthma

COMPLETED PHASE1

Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1

NCT00671229

Healthy Asthma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research procedure will be conducted at University of Kentucky A.B. Chandler Hospital dedicated bronchoscopy suite located on third floor of Pavilion H module room #2, and will be performed only once as part of a standard of care bronchoscopy procedure scheduled by the participants pulmonary physician. This entire study (biopsy) will add 10 minutes or less. Following the biopsy, and after being discharged from the hospital, the participant's study participation will end.

Bronchial Biopsy: The investigator will collect five lung (bronchial) specimens (1-2 cubic millimeters each) from three zones of the participant's airway which will be individually coded, and stored for the computer image analysis of TRPV1 in the investigator's laboratory. Following analysis the samples will be destroyed. The results of the analysis cannot be used for determining a clinical diagnosis. Therefore, the investigator will not provide any findings to either the participant or their physician.

Participants will not get any personal benefit from taking part in this study. Their willingness to take part in this research study, may, in the future help doctors better understand and/or treat patients with asthma.

There will be no cost to the participant for having the bronchial biopsy performed.

Participants will not receive any rewards or payment for taking part in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moderate Persistent Asthma Severe Persistent Asthma Nodule Solitary Pulmonary Pulmonary Atelectasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TRP1 Density

Bronchial Biopsy: During the biopsy procedure the investigator will collect five bronchial specimens (1-2 cubic millimeters) each the major, lobar and segmental bronchi.

Group Type EXPERIMENTAL

Bronchial biopsy

Intervention Type PROCEDURE

Bronchial tissue taken during biopsy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bronchial biopsy

Bronchial tissue taken during biopsy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Competent to understand informed consent
* Diagnosis of moderate to severe persistent allergic asthma.
* Clinical need for diagnostic bronchoscopy for assessment of asthmatic symptoms (e.g., to assess presence of chronic infection with non-tuberculous mycobacteria or other infectious agents as a cause for lack of asthma control) or therapeutic bronchoscopy for management of asthmatic symptoms (e.g., thermoplasty).
* Asthmatic subjects with history of positive skin test to confirm presence of allergy.
* Asthmatic subjects with pre-albuterol forced expiratory volume in the first second (FEV1) of \<70% of the predicted value.
* Non-asthmatic patients will include those patients with solitary pulmonary nodules and healthy individuals with acute lung atelectasis (e.g. airway blocked by mucus plugs or foreign object).
* Scheduled for a diagnostic or therapeutic bronchoscopy procedure.

Exclusion Criteria

* Inability to perform pulmonary function testing
* Unstable asthma control for asthmatic subjects
* An asthma exacerbation within the past month
* History of intubation for asthma
* History of smoking
* History of prematurity
* History of any lung disease or disorder except asthma
* History of congenital or acquired heart disease
* Pregnant/lactating females
* Any serious concurrent systemic disease including but not limited to diabetes, coronary artery disease, vasculitis, etc.
* History of heart arrhythmias including supraventricular tachycardia

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes